METHOD OF DETERMINING INHIBITOR, COVALENTLY BINDING TARGET POLYPEPTIDE Russian patent published in 2015 - IPC C12N15/09 C40B30/02 

Abstract RU 2542963 C2

FIELD: chemistry.

SUBSTANCE: invention relates to the field of biotechnology and can be used for the elaboration of an irreversible inhibitor, covalently binding a target polypeptide. The said method includes: a) presentation of a structural model of the reversible inhibitor or a model of a binding site in the target polypeptide, b) identification of a Cis-residue in the binding site of the target polypeptide, c) supply of the structural model of the supposed irreversible inhibitor, which potentially covalently binds with the target polypeptide, where the inhibitor contains "a warhead", or supply of the structural model of "the warhead" group, d) determination of whether the reactionable group of "the warhead" of the supposed inhibitor is within the distance of the formation of a bond with the Cis-residue in the binding site of the target polypeptide, or identification of a substitutable position of the reversible inhibitor, to which "the warhead" group, capable of forming a covalent bond with the Cis-residue in the binding site of the target polypeptide, can be bound, e) formation of the covalent bond between a sulphur atom of the Cis-residue in the binding site of the target polypeptide and the reactionable "warhead" group or binding "the warhead" group to the substitutable position of the reversible inhibitor.

EFFECT: invention makes it possible to reduce financial and time labour consumption in the elaboration of the structure of the irreversible inhibitor.

41 cl, 11 dwg, 12 tbl, 8 ex

Similar patents RU2542963C2

Title Year Author Number
INHIBITORS OF PROTEASE OF HEPATITIS C VIRUS AND THEIR APPLICATION 2008
  • Niu Dekiang
  • Petter Rassel
  • Singkh Dzhasvinder
  • Kljug Artur F.
  • K'Jao Liksin
RU2523790C2
INHIBITORS OF PROTEASE OF HEPATITIS C VIRUS AND THEIR APPLICATION 2008
  • Petter Rassel
  • Singkh Dzhasvinder
  • Kljug Artur F.
  • Niu Dekiang
  • K'Jao Liksin
  • Gosh Shomir
RU2515318C2
METHOD FOR FINDING LIGANDS 2002
  • Ehrlanson Daniel A.
  • Brajsted Ehndr'Ju S.
  • Uehlls Dzhejms
RU2295518C2
HETEROARYL COMPOUNDS AND USING THEM 2009
  • Kljug Artur F.
  • Petter Rassel S.
  • Tester Richland Vehjn
  • Tsjao Liksin
  • Nju Detsjan
  • Vestlin Vil'Jam Frederik
  • Singkh Dzhasvinder
  • Mazdijasni Khormoz
RU2536584C2
PI3-KINASE INHIBITORS AND USE THEREOF 2010
  • Nyu Detsyan
  • Petter Rassel S.
  • Singkh Dzhasvinder
  • Klyug Artur F.
  • Mazdiyasni Khormoz
  • Chzhu Chzhendon
  • Tsyao Lisin
  • Kuntts Kevin
RU2595718C2
BIFUNCTION CYTOTOXIC AGENTS CONTAINING PHARMACOPHORE CTI 2016
  • Maderna Andreas
  • Subramanyam Chakrapani
  • Tumey Lawrence N.
  • Chen Zecheng
  • Casavant Jeffrey M.
RU2682645C1
HETEROARYL COMPOUNDS AND THEIR APPLICATION 2010
  • Singkh Dzhasvinder
  • Petter Rassel
  • Tester Richland Vejn
  • Klyug Artur F.
  • Mazdiyasni Khormoz
  • Vestlin Iii Vilyam Frederik
  • Nyu Detsyan
  • Tsyao Lisin
RU2636584C2
MODULATION OF STRUCTURED PROTEINS SPECIFICITY 2012
  • Tajt Dzhon
  • Uoker Edvard
  • Stejs Ketrin
  • Tyufel Deniel
RU2631931C2
ETOPOSIDE AND DOXORUBICIN CONJUGATES FOR DRUG DELIVERY 2009
  • Demole Mishel'
  • Che Kristian
  • Gabatuler Rajnkhard
  • Jang Gaotsjan
RU2531591C2
IMIDE MODULATORS OF PROTEOLYSIS AND METHODS FOR USING THEM 2015
  • Kruz Krejg
  • Kryu Endryu P.
  • Dun Khantsin
  • Van Tszin
  • Tsian Imin
  • Tszin Mejchzhun
RU2738833C2

RU 2 542 963 C2

Authors

Singkh Dzhasvinder

Petter Rassel Kolin

Nju Dehtsjan

Dates

2015-02-27Published

2009-09-04Filed